
Flow cytometric analysis of WiDr cells (right histogram) labeling FBXO34 with ab175296 at 1/10 dilution compared to a negative control cell (left histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.

Immunohistochemical analysis of formalin fixed and paraffin embedded Human colon carcinoma tissue labeling FBXO34 with ab175296 at 1/50 dilution, followed by peroxidase conjugation of the secondary antibody and DAB staining.

Anti-FBXO34 antibody - C-terminal (ab175296) at 1/1000 dilution + CHO cell line lysate at 35 µgdeveloped using the ECL technique